BCC-903

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBCC-903
Drug Alias NameBCC-903
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSkin NeoplasmsCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAquavit Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSkin NeoplasmsCarcinoma, Basal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A